CZMWY

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Carl Zeiss Meditec A G

CEO
Ludwin Monz
Employees
0
Headquarters

Goeschwitzer Strasse 51-52
Jena, Thueringen 07745
Phone: 4936412200
https://www.zeiss.de/meditec-ag/

News

Carl Zeiss Meditec Q1 EBIT Slips, But Revenue Climbs
Feb 09, 2024 07:06am

JENA (dpa-AFX) - Carl Zeiss Meditec AG (CZMWF.PK), a medical technology firm, on Friday reported a decline in earnings before interest and taxes or EBIT for the first-quarter. However, the company…


Source:Finanz Nachrichten
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
Feb 09, 2024 06:00am

EQS-News: Carl Zeiss Meditec AG / Key word(s): Quarterly / Interim Statement/Quarter Results Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24 09.02.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Carl Zeiss Meditec achieves Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
Jan 29, 2024 10:11am

Carl Zeiss Meditec AG / Key word(s): Share Buyback Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m 29-Jan-2024 / 11:11 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m Jena, 29 January 2024 The Management Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has, with the approval of the Supervisory Board today, agreed to launch a share buyback program. Under the share buyback program, own shares will be purchased for an amount of up to €150m. Based on XETRA closing price of €98.48 as of 26 January 2024, this corresponds to up to 1,523,151 shares (approx. 1.7% of share capital). The shares are to be bought back via the stock exchange in one or more separate tranches. To do this, the company shall exercise the authorization granted by the company''s Annual General Meeting on 6 August 2020.


Source:EQS News
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
Jan 29, 2024 10:11am

EQS-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Share Buyback Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m 29-Jan-2024 / 11:11 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible


Source:Wallstreet:Online
Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: ''Innovation Is Key''
Jan 23, 2024 17:47pm

Innovation and digitalization have been in focus among ophthalmology majors . The ophthalmology market is attractive, at an estimated $34 billion, with growth rates “in the mid-single digits across products that range from the clinic to the operating room to the pharmacy,” analyst Susannah Ludwig of Bernstein said in a note. Initiated coverage of Alcon AG (NYSE: ALC ) with an Outperform rating and a price target of CHF 82 ($94.03). Initiated coverage of Carl Zeiss Meditec AG (OTC: CZMWY ) with an Underperform rating and a price target of €76 ($82.31). Check out … Full story available on Benzinga.com


Source:Benzinga
Carl Zeiss Meditec AG: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
Jan 11, 2024 12:06pm

The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements. DUBLIN, Calif. and JENA, Germany, Jan. 11, …


Source:Finanz Nachrichten